Sponsors

The need for POCT teams to operate as business units

Tony Cambridge explains why he believes that POCT services must be run as business units, led by qualified individuals and supported by organisation leads and wider network influence.

The healthcare landscape is changing at a rapid pace with more emphasis on value-based care, budgetary control and improved clinical outcomes for patients. Point-of-care testing (POCT) is one of the specialist areas that continues to grow in diversity, scope and impact. It is my belief that point-of-care (POC) services must be run as business units, led by qualified individuals and supported by organisation leads and wider network influence.

The financial element of healthcare is often lost on some, with the focus being solely on patient outcomes regardless of cost. This is an admirable approach and clearly puts the patient at the centre of care delivery. In the real world of financial constraints this is not an approach that can be sustained, with limited budgets, value on investment considerations and accountability for spending public or company money.

This article aims to demonstrate how POC services must be run as a business, and what needs to be in place to achieve this. After many years of successfully implementing change whilst delivering financial value and running my own company, I can say that following this guidance will support your current service or the transition required to act like a business.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

Fresh muscle biopsies webinar

Online
11 December, 2025

POCT Innovators - The power to disrupt through diagnostics

National Army Museum, Chelsea, London
15 December, 2025

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026